NCT03051464 2026-02-17
Morpheus
Sir Mortimer B. Davis - Jewish General Hospital
Phase 2/3 Recruiting
Clinical Trials
4 trialsNCT04749108 2026-02-05
GRECCAR14
Institut du Cancer de Montpellier - Val d'Aurelle
Phase 2/3 Recruiting
NCT07321847 2026-01-07
INJECTABL-3
Immunophotonics, Inc.
Phase 2/3 Not yet recruiting
NCT05215379 2026-01-02
Neoadjuvant Chemoradiation Therapy Combined With Immunotherapy for MSS Ultra-low Rectal Cancer
Changhai Hospital
Phase 2/3 Completed